Guillain-Barré Foundation: Paving the Way for Access to Vital Treatments Worldwide
Pheresis Technology is proud to highlight the efforts of the Guillain-Barré Foundation, an organization dedicated to providing critical health services for patients with immunological diseases and other life-threatening conditions. With a particular focus on Guillain-Barré syndrome, the foundation aims to address the growing health crisis affecting many individuals in Ecuador and throughout Latin America.
Commitment to Health
The Guillain-Barré Foundation was established to fund essential treatments for patients suffering from conditions such as Guillain-Barré syndrome, myasthenia gravis, hepatic cirrhosis, rheumatoid arthritis, lupus, and atherosclerosis. Since the COVID-19 pandemic, the number of Guillain-Barré cases has significantly increased, highlighting the urgent need for a comprehensive approach that not only provides treatment but also enhances the quality of life for these patients.
The Reality in Ecuador
Access to critical treatments such as plasmapheresis presents a significant challenge in Ecuador and across Latin America. The costs of these procedures, which range from $1,800 to $4,000 per session, are prohibitive for a large segment of the population. With over 35% of Ecuador's population living in poverty and more than 50% in rural areas facing extreme poverty, many families cannot afford these vital treatments.
The situation is further complicated in public hospitals, which often lack the resources and equipment necessary to perform plasmapheresis procedures. As a result, thousands of patients find themselves in a desperate position, facing medical abandonment that jeopardizes their lives.
The situation is further complicated in public hospitals, which often lack the resources and equipment necessary to perform plasmapheresis procedures. As a result, thousands of patients find themselves in a desperate position, facing medical abandonment that jeopardizes their lives.
A Necessary Response
In light of this alarming crisis, the Guillain-Barré Foundation has partnered with Apheresis Technology, a company committed to addressing the issue of access to treatments. Together, they are working to break monopolies and reduce the costs of plasmapheresis worldwide. This collaboration has successfully connected advanced technology with medical services, making essential treatments more accessible and affordable.
Currently, Apheresis Technology operates internationally, providing crucial support to the Guillain-Barré Foundation in its mission to finance critical treatments and save lives.
Currently, Apheresis Technology operates internationally, providing crucial support to the Guillain-Barré Foundation in its mission to finance critical treatments and save lives.
Achievements and Projections
In the past year, the collaboration between the Guillain-Barré Foundation and Apheresis Technology has funded 14 procedures for 6 patients in Ecuador and Mexico, in partnership with the Autonomous University of Puebla. This initiative has established the foundation as the first international organization dedicated to facilitating access to plasmapheresis treatments for immunological diseases, with a focus on the most vulnerable communities, especially in Tungurahua, Ecuador.
To continue expanding its impact, the Guillain-Barré Foundation is committed to ensuring that families facing serious illnesses have access to the treatments they need, regardless of their financial situation. While the public healthcare system still fails to meet this urgent need, the foundation works tirelessly to dismantle barriers and ensure that health is a universal right.
To continue expanding its impact, the Guillain-Barré Foundation is committed to ensuring that families facing serious illnesses have access to the treatments they need, regardless of their financial situation. While the public healthcare system still fails to meet this urgent need, the foundation works tirelessly to dismantle barriers and ensure that health is a universal right.
Conclusion
The Guillain-Barré Foundation, with the support of Apheresis Technology, stands at the forefront of a vital fight for access to medical treatments worldwide. Their mission is clear: to ensure that no one is left behind in the pursuit of health. As they continue their work, they invite the community to join their cause in building a more just and compassionate future for all.
For more information about the Guillain-Barré Foundation and how you can support this noble cause, please visit our website or contact us through the following channels:
Contact:
Alexey Zumbana
Phone: 0962803109
Email: Apheresistechnology@gmail.com
For more information about the Guillain-Barré Foundation and how you can support this noble cause, please visit our website or contact us through the following channels:
Contact:
Alexey Zumbana
Phone: 0962803109
Email: Apheresistechnology@gmail.com
